Le Lézard
Classified in: Health, Science and technology
Subject: PER

Adam Wallace Named Chief Technology Officer at Transaction Data Systems (TDS)

OCOEE, Fla., April 17, 2019 /PRNewswire/ -- Transaction Data Systems (TDS), parent company of the Rx30 and Computer-Rx pharmacy management systems, publicly announced today the addition of Adam Wallace to the executive team. An experienced leader of software product development organizations in high-energy, growth-oriented settings, ranging from startups to Fortune 100 companies, Wallace has a consistent track record of aligning technology teams with business goals to deliver successful software solutions.

Adam Wallace named Transaction Data Systems Chief Technology Officer

Wallace brings over 20 years of technology experience to TDS, having held leadership positions with a range of organizations including Oracle, Explorys, BEA, MRI Software, and Flashline. Throughout his career, Wallace has successfully scaled and developed teams by focusing on organization design, Agile methodologies and process improvement. Previously honored in Computerworld magazine's as one of the "Premier 100 IT Leaders," Wallace takes the helm as the development and technology leader providing both vision and daily leadership to the teams responsible for a myriad of software products, including Computer-Rx and Rx30 pharmacy management systems.

"Innovation and leadership in the technology offered to independent pharmacies is a core focus for TDS. After an exhaustive search for the right fit to continue driving TDS forward as a technology leader in the industry, Adam Wallace's experience, innovation-focused mindset and solid visionary approach to leadership made him the clear choice to lead the technology teams at Transaction Data Systems going forward," said TDS Chief Executive Officer, Jude Dieterman.

Prior to joining TDS, Wallace was a senior leader of product development at a leading provider of software applications and hosted solutions for the global real estate property management industries. Responsible for all aspects of software engineering, quality assurance, and release engineering at TDS, Wallace brings a growth and innovation-focused approach to the technology the organization provides its customers.  

"Every phase of an organization's growth requires a specific set of expertise in its leaders. I believe the addition of Adam Wallace to the TDS leadership team brings the ideal set of leadership skills, vision and experience to drive Transaction Data Systems into the future of pharmacy management software," said TDS President and COO, Kevin Lathrop. "Our customers deserve the absolute best in technology, service, support and thought leadership from TDS, and we will continue to make strong, deliberate strides to achieve and maintain that ideal for our customers."

About Transaction Data Systems (TDS)
For the past 41 years, TDS has been dedicated to the success of independent pharmacy. TDS, with its family of products and services including Rx30, Computer-Rx, Enhanced Medication Services and Pharm Assess RBS, provides pharmacy systems and other innovative technology to the pharmacy industry. Its proven pharmacy management software and its continually growing and evolving products and services offer pharmacies the technology and support they need to succeed in a dynamic marketplace. Proudly supporting the largest install base of independent pharmacies in the industry with systems in all 50 states and the Virgin Islands, TDS is the unquestioned leader in Independent Pharmacy Management Software. For more information about TDS, please visit tdsclinical.com.

TDS logo with brands (PRNewsfoto/Transaction Data Systems)

SOURCE Transaction Data Systems

These press releases may also interest you

at 07:55
LexaGene Holdings Inc. (the "Company"), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers, announced today that its LX technology can successfully detect single-point gene mutations from cheek...

at 07:48
CollabNet VersionOne (www.collabnet.com), a global leader in Enterprise Value Stream Management, Agile management, Git version control and DevOps, today announced it will present and co-sponsor Capgemini DevOps Series -Toronto on April 25, 2019. In...

at 07:47
Today, the Global Food Safety Initiative (GFSI) announced the launch of the all-new GFSI Experts Series, a curated collection of interviews with leaders from across the food industry, academia and the public sector. The open-access series allows...

at 07:45
Allied Market Research recently published a report, titled, Pathological Examination Market by Type (Traditional Pathology and Digital Pathology) and Application (Digestive Organs and Other Applications): Global Opportunity Analysis and Industry...

at 07:37
MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today provided a business update for the first quarter ended March 31, 2019. Michael K. McGarrity, Chief Executive Officer of...

at 07:35
Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for people with neurological diseases, announced today that the results of the Phase 2 study of its lead compound, CX-8998,...

News published on 17 april 2019 at 13:43 and distributed by: